National Neuroscience Institute
Clinical trials sponsored by National Neuroscience Institute, explained in plain language.
-
Gene test could prevent second strokes in High-Risk patients
Disease control OngoingThis study looks at whether genetic testing can help doctors pick the right blood thinner for people who have had a stroke or mini-stroke. About 350 patients will be randomly assigned to either standard care or a genetic test that checks if a common drug, clopidogrel, will work f…
Phase: NA • Sponsor: National Neuroscience Institute • Aim: Disease control
Last updated May 17, 2026 12:57 UTC
-
New hope for aggressive brain cancer: targeted drug shows promise in early trial
Disease control TerminatedThis study tests a drug called ACT001 in adults whose glioblastoma (a severe brain cancer) has come back after standard treatment. Only patients with a specific genetic marker (STAT3-high) are included. The goal is to see if the drug can shrink the tumor or keep it stable for at …
Phase: PHASE2 • Sponsor: National Neuroscience Institute • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Could a vitamin e compound slow Parkinson's? new trial aims to find out
Disease control OngoingThis study tests whether a daily supplement called tocotrienol (a form of vitamin E) can slow the worsening of movement problems in people with Parkinson's disease. One hundred adults with Parkinson's will take either the supplement or a placebo for two years. Researchers will tr…
Phase: PHASE2 • Sponsor: National Neuroscience Institute • Aim: Disease control
Last updated May 04, 2026 16:24 UTC